Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the recurrence risk of cardiovascular events in
patients with type 2 diabetes mellitus and coronary heart disease after different
antidiabetic drug therapy (glipizide or metformin) by using an double-blind, randomized,
parallel control and prospective study
The end point of this study is:
1. follow up 3yr
2. recurrence of cardiovascular event
3. death caused by other reasons such as stroke, uremia, blindness and amputation